Alzheimer’s Disease

Fluid biomarkers of immune function in Alzheimer’s disease

Deep molecular profiling to identify new genetic variants and drug targets in Alzheimer’s disease

Optimized anti-Aβ vaccination enters clinical trials in Alzheimer’s disease

Combining genetics and molecular biomarkers for Alzheimer’s disease prognostication

Apathy in dementia

Reactive astrocytes as therapeutic targets in neurodegenerative disease

Impact of race and ethnicity on greenspace-brain health associations

Diverse ancestral populations and the ADSP

Importance of ancestral background in conferring risk for genetic factors in Alzheimer’s disease

Can astrocytes influence neuropsychiatric symptoms in neurodegenerative disease?

Optimizing neighborhood and community factors for improved brain aging

Targeting soluble TNF to attenuate neuroinflammation in Alzheimer’s disease

Targeting synaptic function and recovery to tackle cognitive function

Blood biomarkers in Alzheimer’s disease: appropriate use recommendations

The pathophysiological link between traumatic brain injury and Alzheimer’s disease

Human iPSC-derived retinal organoids as a model for Alzheimer’s disease retinal histopathology